Andreas Naegeli
Head of Business Development Genovis
Seminars
Tuesday 13th October 2026
GlyCLICK: Showcasing a Precise & Versatile Conjugation Platform for Improved ADCs
3:30 pm
- Showcasing GlyCLICK site specific conjugation that produces homogeneous ADCs with a defined DAR while preserving antibody function
- Exploring how the platform supports controlled ADC generation and applies to a wide range of antibody formats and payloads
- Laying out case studies and preclinical examples demonstrate how GlyCLICK is used in the development of novel ADCs
